Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF-Reference-Cited by-同舟云学术

Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF

Published:2018-01 Issue: Volume:64 Page:35-40
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Heltshe Sonya L.^ORCID,West Natalie E.,VanDevanter Donald R.,Sanders D.B.,Beckett Valeria V.,Flume Patrick A.,Goss Christopher H.

Funder

Cystic Fibrosis Foundation Therapeutics

NIH

South Carolina Clinical Translational Research (SCTR) Institute

Medical University of South Carolina

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference34 articles.

1. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis;Konstan;J. Pediatr.,2007

2. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis;Waters;Eur. Respir. J.,2012

3. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis;de Boer;Thorax,2011

4. Predictive 5-year survivorship model of cystic fibrosis;Liou;Am. J. Epidemiol.,2001

5. Annual Data Report 2015;Cystic Fibrosis Foundation Patient Registry,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations;Journal of Cystic Fibrosis;2024-07

2. Challenges to the optimisation of cystic fibrosis exacerbation treatment outcomes;European Respiratory Journal;2024-06

3. Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis;Annals of the American Thoracic Society;2023-12-14

4. Home‐spirometry exacerbation profiles in children with cystic fibrosis;Pediatric Pulmonology;2023-11-28

5. Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location;Journal of Cystic Fibrosis;2023-10